about
Structural insight into the inhibition of human kynurenine aminotransferase I/glutamine transaminase KSubstrate specificity and structure of human aminoadipate aminotransferase/kynurenine aminotransferase IIDownregulated kynurenine 3-monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypes.Biochemical and structural properties of mouse kynurenine aminotransferase IIIKynurenine Aminotransferase Isozyme Inhibitors: A ReviewEndotoxin-Induced Tryptophan Degradation along the Kynurenine Pathway: The Role of Indolamine 2,3-Dioxygenase and Aryl Hydrocarbon Receptor-Mediated Immunosuppressive Effects in Endotoxin Tolerance and Cancer and Its Implications for ImmunoparalysisCrystal structure of human kynurenine aminotransferase IIStructure, expression, and function of kynurenine aminotransferases in human and rodent brainsTargeted Deletion of Kynurenine 3-Monooxygenase in Mice: A NEW TOOL FOR STUDYING KYNURENINE PATHWAY METABOLISM IN PERIPHERY AND BRAINAntipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotectionBehavioral disturbances in adult mice following neonatal virus infection or kynurenine treatment--role of brain kynurenic acid.Metabolomic analysis reveals metabolic disturbance in the cortex and hippocampus of subchronic MK-801 treated ratsThe BTBR mouse model of autism spectrum disorders has learning and attentional impairments and alterations in acetylcholine and kynurenic acid in prefrontal cortex.Age dependency of inhibition of alpha7 nicotinic receptors and tonically active N-methyl-D-aspartate receptors by endogenously produced kynurenic acid in the brainA systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of ratsImpaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia.The NMDA receptor co-agonists, D-serine and glycine, regulate neuronal dendritic architecture in the somatosensory cortex.Kynurenic acid and 3-hydroxykynurenine production from D-kynurenine in mice.Frontal lobe alterations in schizophrenia: a review.Serum concentrations of kynurenines in adult patients with attention-deficit hyperactivity disorder (ADHD): a case-control study.Kynurenic Acid Metabolism in Various Types of Brain Pathology in HIV-1 Infected Patients.Exposure to kynurenic acid during adolescence produces memory deficits in adulthood.Anthranilic Acid: A Potential Biomarker and Treatment Target for SchizophreniaPerinatal complications and schizophrenia: involvement of the immune system.Sustained elevation of kynurenic Acid in the cerebrospinal fluid of patients with herpes simplex virus type 1 encephalitis.Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis.Discovery of Brain-Penetrant, Irreversible Kynurenine Aminotransferase II Inhibitors for Schizophrenia.On the relationship between the two branches of the kynurenine pathway in the rat brain in vivo.Kynurenine and Tryptophan Levels in Patients With Schizophrenia and Elevated Antigliadin Immunoglobulin G Antibodies.Src kinase as a mediator of convergent molecular abnormalities leading to NMDAR hypoactivity in schizophrenia.Synthesis and characterization of iron(II) quinaldate complexes.Amino acids inhibit kynurenic acid formation via suppression of kynurenine uptake or kynurenic acid synthesis in rat brain in vitro.Activation of indoleamine 2,3-dioxygenase by LPS in a porcine model.The role of microbiota in the pathogenesis of schizophrenia and major depressive disorder and the possibility of targeting microbiota as a treatment option.Inhibition of Large Neutral Amino Acid Transporters Suppresses Kynurenic Acid Production Via Inhibition of Kynurenine Uptake in Rodent Brain.The Carnitine Palmitoyl Transferase (CPT) System and Possible Relevance for Neuropsychiatric and Neurological Conditions.Absence of aryl hydrocarbon receptors increases endogenous kynurenic acid levels and protects mouse brain against excitotoxic insult and oxidative stress.High tryptophan diet reduces extracellular dopamine release via kynurenic acid production in rat striatum.Kynurenic Acid: The Janus-Faced Role of an Immunomodulatory Tryptophan Metabolite and Its Link to Pathological Conditions.Synganglion histology in different stages of Rhipicephalus sanguineus ticks (Acari: Ixodidae).
P2860
Q24311414-964CC99F-DAC4-4764-A6BE-C411E1851283Q24312770-5F7B75F0-BF94-4E49-AACC-0EADC40C8CD0Q24631189-55C5A5DA-7A49-4205-B369-8912854BF708Q24645615-321516F5-6C86-4D27-8C7B-2BF2EE41B274Q26744492-C62C9701-DB60-458E-8F66-F48060E5EBCFQ26765777-589B510E-D55D-413B-9D43-EA34F1A76059Q27649207-7F81D519-C30A-405C-A394-12A04A043ED2Q27657768-9D660F74-1CC1-4FE1-B4EC-725EFA2427C8Q29306917-DCC8386B-464A-40B7-B0CC-41BFC77C8F9AQ30386608-394EF23C-D52D-4850-9540-70B147856634Q30419650-DE6EE50B-C12D-4AF9-88D2-CA40944AADE5Q34663830-C71C99B1-E9A6-4D4F-AC83-0D66A826E2DDQ34701031-3D9EC3EF-3E9A-4884-96E2-74027FF4B8EBQ35003093-8E0E335B-CA92-4428-9C3B-B367378A1E73Q35213516-92891E54-B312-4620-83AC-4D82737B0FEFQ35390305-D0563C45-895F-4EBA-B134-6923D5B878E6Q35675159-513C7482-5196-4D81-927B-AFAFFF061B74Q35923160-2B24930E-33F6-4010-AF35-61E862710F6AQ36246546-E7F5AA85-9C01-402D-81EE-F8B95C235F64Q36256757-3736F40D-03D4-45E0-A285-61CD244B98B1Q36482308-20B065A7-876F-4095-ADD6-9C6597C9F991Q36623248-2DD12126-ABB5-4BAF-B19A-AD19BFD68C15Q36756944-0323547B-9A62-40EC-A6D0-31942C06647CQ36952179-ECCC2E26-6226-4FDA-8B07-EDC2EB24349FQ37373503-32D88521-5164-45C9-810C-C503F3CA8F3EQ39130393-1182D7E0-B7A3-4F06-BF97-87E03F8D1364Q39736371-270CA8CA-82C3-43F8-B047-D509BF428BA4Q41139088-136AE7B4-423D-41F5-AE77-41CE438F7D06Q41656861-D4332643-68FC-4752-B497-F0237F769E28Q42352815-A4ADAD15-09CC-4D59-85C3-6A83E5BA1BADQ42909812-A1B69BDB-CB9C-44B6-86AD-F0E70B702556Q43134681-04B0FD18-2E4C-49E8-9D1B-DFF821D7AFC2Q46859808-1B85F73A-21D0-49DF-ACD9-AAD867B3AF2EQ47107960-F46887BB-2DCD-4811-B35F-49CD854A5BD3Q48055959-18CA6EE6-3AEE-4AC5-98FE-8E5CE481FCFDQ48146067-CD4FA738-72DD-49D0-9E1F-CDED28690E52Q48158678-59AC6EAE-00EF-4B15-91E6-B50C40646DCEQ49117944-59621DFA-8490-436B-9AC8-5B7B50A3BC86Q49328492-AC8C57AE-7635-4568-B1D8-3E33E28D3AFCQ53194295-BB89AA01-1B5D-43ED-8B9E-32A4D5CCB5B1
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The kynurenic acid hypothesis of schizophrenia
@ast
The kynurenic acid hypothesis of schizophrenia
@en
The kynurenic acid hypothesis of schizophrenia
@nl
type
label
The kynurenic acid hypothesis of schizophrenia
@ast
The kynurenic acid hypothesis of schizophrenia
@en
The kynurenic acid hypothesis of schizophrenia
@nl
prefLabel
The kynurenic acid hypothesis of schizophrenia
@ast
The kynurenic acid hypothesis of schizophrenia
@en
The kynurenic acid hypothesis of schizophrenia
@nl
P2093
P3181
P1476
The kynurenic acid hypothesis of schizophrenia
@en
P2093
Göran Engberg
Klas Linderholm
Lilly Schwieler
Linda Nilsson
P3181
P356
10.1016/J.PHYSBEH.2007.05.025
P407
P577
2007-09-10T00:00:00Z